Blue light therapy shows promise for vitiligo repigmentation
NCT ID NCT07174024
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study compared blue light therapy to targeted narrow band UVB for treating stable non-segmental vitiligo in 30 patients. The goal was to see which treatment better restores skin color. Both are light-based therapies, but blue light may be less harsh on the skin.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- blue light emitting diode therapy and narrow band UVB phototherapy
- What this could lead to
- If blue light works as well as UVB, it could offer a gentler, more convenient option for repigmenting vitiligo patches.
- What could go wrong
- This is a small, completed Phase 4 trial with only 30 patients, so results may not apply to everyone. Blue light may be less effective or cause side effects like skin sensitivity.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VITILIGO are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Cairo University
Giza, Cairo Governorate, 13114, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can Real-World data unlock better skin disease care?
- New ointment aims to restore skin color in vitiligo
- Skin microbes linked to vitiligo and immunotherapy reactions in melanoma patients
- New vitiligo registry aims to uncover disease trends in 2,500 patients
- Scientists probe immune secrets of four skin diseases
- Lamp vs laser: which light works best for vitiligo?